ARTICLE | Emerging Company Profile
Mermaid: taking antibodies below the cell surface
Australian-German newco is delivering antibody therapies inside liver cells by encoding them as mRNA
May 2, 2022 11:50 PM UTC
Mermaid is aiming to expand the target scope of antibodies by taking them inside the cell where traditional mAbs don’t reach.
Seizing on the moment, the Australia and Germany-based newco is marrying proof of concept from COVID-19 vaccines for lipid nanoparticle-based delivery of mRNA-encoded proteins with patent expirations on Nanobodies to create a system that can express Nanobodies inside cells...